Thrombocytosis is a condition where your blood contains too many platelets, specifically a count at or above 450,000 per microliter of blood. Platelets are small cell fragments that help your blood clot, and having too many of them can sometimes increase the risk of abnormal clotting or, paradoxically, bleeding. In most cases, a high platelet count shows up on routine blood work and is caused by something else going on in your body, like an infection or inflammation.
Two Types of Thrombocytosis
A high platelet count falls into one of two categories, and the distinction matters because it determines what happens next.
Reactive (secondary) thrombocytosis is by far the more common type. Your platelet count rises in response to another condition: an infection, surgery, inflammation, or iron deficiency. Your bone marrow is working normally but producing extra platelets because your body is signaling it to do so. Once the underlying cause is treated or resolves on its own, the platelet count typically returns to normal.
Essential thrombocythemia (primary thrombocytosis) is a bone marrow disorder where the marrow overproduces platelets on its own, without an outside trigger. This is caused by genetic mutations in the blood-forming cells of the bone marrow. About 55% of people with essential thrombocythemia carry a mutation in the JAK2 gene, 27% have a CALR mutation, and 5% have an MPL mutation. The remaining 13% test negative for all three. Essential thrombocythemia is much less common than the reactive type and is classified as a chronic blood cancer, though many people live with it for decades.
Common Causes of Reactive Thrombocytosis
Because reactive thrombocytosis is a response to something else, the list of potential triggers is long. Infections are one of the most frequent causes, particularly in children, whose immune systems are still developing and who tend to get sick more often. Chronic inflammatory conditions like rheumatoid arthritis or inflammatory bowel disease can keep platelet counts elevated for extended periods. Iron deficiency is another well-known trigger, and simply correcting the deficiency often brings the count back down.
Spleen removal (splenectomy) reliably causes a spike in platelets because the spleen is the primary site where old platelets are destroyed. Without it, platelets accumulate. Roughly 75% to 82% of people who have their spleen removed develop thrombocytosis afterward. Platelet counts typically increase by 30% to 100%, peaking one to three weeks after surgery, then gradually returning to normal over weeks or months.
Surgery, trauma, and major blood loss can also trigger a temporary rise. In most of these situations, the elevated count is a byproduct and not the main problem.
Symptoms to Recognize
Many people with thrombocytosis have no symptoms at all, and the condition is discovered only through a blood test. When symptoms do appear, they tend to be more common in essential thrombocythemia than in the reactive type.
Headaches are the most frequent complaint. Some people experience visual disturbances, including blurred vision or brief episodes of double vision that resolve on their own. Lightheadedness, atypical chest pain, and tingling or numbness in the hands and feet also occur. These are called vasomotor symptoms because they stem from changes in blood flow through small vessels.
One particularly distinctive symptom is erythromelalgia: a burning, painful sensation in the toes (and sometimes fingers) that can progress to redness and even small ulcers. It responds well to low-dose aspirin, and its presence often points doctors toward a primary bone marrow disorder rather than a reactive cause. Some neurological symptoms in essential thrombocythemia closely mimic migraine aura, which can make diagnosis tricky.
How Thrombocytosis Is Diagnosed
The starting point is a complete blood count (CBC), which measures your platelet count along with red and white blood cells. If the count comes back at or above 450,000 per microliter, the next step is confirming it’s real and persistent. A peripheral blood smear, where a technician examines a drop of your blood under a microscope, verifies the count and checks for abnormal-looking cells.
From there, the diagnostic work focuses on figuring out whether the high count is reactive or primary. Your doctor will look for obvious triggers: recent surgery, active infection, iron deficiency, or chronic inflammation. Blood tests for inflammatory markers and iron levels can help narrow things down. If no reactive cause is found and the platelet count stays elevated, genetic testing for JAK2, CALR, and MPL mutations is the next step. A bone marrow biopsy may also be needed, both to look for the characteristic cell changes of essential thrombocythemia and to rule out other bone marrow disorders.
Risks and Complications
Reactive thrombocytosis carries a low risk of complications on its own. The elevated platelets are normal in structure and function, and the count comes down once the trigger resolves. The real concern lies with essential thrombocythemia, where the risk of blood clots, both arterial (strokes, heart attacks) and venous (deep vein thrombosis, pulmonary embolism), is genuinely elevated.
People over 60 and those with a history of prior blood clots are considered high risk for thrombotic events. Counterintuitively, extremely high platelet counts (above 1.5 million per microliter) can actually cause bleeding rather than clotting. This happens because the excess platelets consume a clotting protein called von Willebrand factor, creating an acquired bleeding disorder.
Treatment Approaches
For reactive thrombocytosis, treatment targets the underlying cause. If the trigger is an infection, treating the infection resolves the high count. If it’s iron deficiency, iron supplementation does the job. The platelets themselves don’t need direct treatment.
Essential thrombocythemia is managed differently depending on your risk level. Most patients take low-dose aspirin (75 to 100 mg daily) to reduce the risk of clotting events. For high-risk patients, meaning those over 60 or with a history of blood clots, a medication that slows platelet production is added. This cytoreductive therapy aims to bring the platelet count into the 200,000 to 400,000 range. However, for people aged 40 to 59 without high-risk features and with platelet counts below 1.5 million, adding cytoreductive therapy to aspirin has not been shown to reduce vascular events, progression to scarring of the bone marrow, or transformation to leukemia. In other words, aspirin alone is sufficient for many intermediate-risk patients.
Thrombocytosis in Children
High platelet counts are common in young children, often triggered by routine infections and inflammatory illnesses. Infants and toddlers naturally run higher platelet counts than adults. Normal values in children under 6 can reach as high as 650,000 per microliter at around 2 months of age, gradually declining to the adult threshold of 450,000 by school age. This means a count that would be flagged as abnormal in an adult may be perfectly normal in a toddler.
Essential thrombocythemia is rare in children, with an annual incidence of only 0.004 to 0.11 per 100,000, compared to about 1 per 100,000 in adults. When it does occur, it looks genetically different: roughly 75% of children diagnosed with essential thrombocythemia test negative for all three major driver mutations, compared to only 13% of adults. This means the standard genetic tests used in adults are less useful in children, and a more extensive workup is often necessary.